Profiel
Per Åke Filip Nilsson has held the title of Chief Product Officer at Pilloxa AB since 2015, which is a company he founded in the same year.
Actieve functies van Per Åke Filip Nilsson
| Bedrijven | Functie | Begin |
|---|---|---|
Pilloxa AB
 Pilloxa AB Internet Software/ServicesTechnology Services Part of iZafe Group AB, Pilloxa AB is a Swedish company that develops apps for patients to support them in adhering to their treatment and to connect patients, healthcare providers, and the pharmaceutical industry. The company is based in Stockholm, Sweden. Pilloxa was acquired by iZafe Group AB on November 28, 2022 for $1.32 million. The company provides a SaaS platform where pharmaceutical companies and other customers can design digital patient support quickly, securely, and at a low cost. Pilloxa's self-developed smart medication dose can also be connected to the service to support patients in taking the correct medication. The company was founded in 2015 by Helena Rönnqvist, Francesco Mazzotta, Per Åke Filip Nilsson. Helena Rönnqvist has been the CEO since 2015. | Oprichter | 01-01-2015 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Pilloxa AB
Pilloxa AB Internet Software/ServicesTechnology Services Part of iZafe Group AB, Pilloxa AB is a Swedish company that develops apps for patients to support them in adhering to their treatment and to connect patients, healthcare providers, and the pharmaceutical industry. The company is based in Stockholm, Sweden. Pilloxa was acquired by iZafe Group AB on November 28, 2022 for $1.32 million. The company provides a SaaS platform where pharmaceutical companies and other customers can design digital patient support quickly, securely, and at a low cost. Pilloxa's self-developed smart medication dose can also be connected to the service to support patients in taking the correct medication. The company was founded in 2015 by Helena Rönnqvist, Francesco Mazzotta, Per Åke Filip Nilsson. Helena Rönnqvist has been the CEO since 2015. | Technology Services |
